- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Piramal Pharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (80), financial health (95), director (85) and company-foundation signals.
- Operating for 6 years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2025.
- Positive net worth.
- 12 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Piramal Pharma
Piramal Pharma is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24297MH2020PLC338592). Business overview includes Pharma (Drug Formulation & Development), incorporated on March 04, 2020 (6+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status.
- Location Gr. Flr., Piramal Ananta, Agastya Corp. Park, Kamani Junction, Lbs Marg, Kurla, Mumbai, Maharashtra - 400070
- Website piramal.com
Financial Performance of Piramal Pharma
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Piramal Pharma (12)
Charges of Piramal Pharma
| Lender | Amount | Status |
|---|---|---|
|
Idbi Trusteeship Services Limited
Creation Date: 19 May 2025 |
300.00 cr | Open |
|
Idbi Trusteeship Services Limited
Creation Date: 12 Dec 2024 |
100.00 cr | Open |
|
Idbi Trusteeship Services Limited
Creation Date: 10 Dec 2024 |
200.00 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
